Sanjay Agarwal MD FACE FACP FRSSDIRakesh Sahay MD DM FACE FAMS FICP FSLCE
Innehållsförteckning
Section 1: Introduction1. History of Insulin2. Insulin Use in India's ChallengesSection 2: Basic Physiology and Pharmacology3. Physiology of Insulin Secretion4. Taxonomy of Insulin5. Insulin AnalogsSection 3: Insulin Guidelines6. Choosing an Insulin Regimen: Pragmatic Guidance7. International Guideline Recommendations for Insulin Initiation8. International Guidelines Recommendations for Insulin Intensification9. South Asian Guidelines on Insulin Therapy10. Insulin Monograph: Review of Important Clinical Trials with InsulinSection 4: Clinical Insulinology11. Premixed Insulin in Clinical Practice12. High-mix Insulins13. Basal Insulin14. Insulin with Glucagon-like Peptide-1 Receptor AgonistCoformulations15. Insulin Coformulations (Insulin Degludec/Insulin Aspart)Section 5: Advances in Insulin16. Noninjectable Insulin17. Ultrafast-acting Insulin18. Smart Insulin19. Insulin Delivery Devices: From Then to Now20. Insulin Pump Therapy in Diabetes21. Newer Insulins on the HorizonSection 6: Special Populations22. Insulin in Type 1 Diabetes Mellitus23. Insulin in Renal Impairment24. Insulin in the Elderly25. Insulin Therapy in Diabetes and Pregnancy26. Insulin in InfantsSection 7: Special Situations27. Insulin Use in Complicated Diabetic Infections28. Nondiabetic Use of Insulin29. Insulin in Diabetic Ketoacidosis and Other AcuteHyperglycemic Conditions30. Hypoglycemia Prone PatientsSection 8: Technique and Monitoring31. Insulin Technique: Simply Fitter32. Insulin Storage in Extreme Climates33. Self-monitoring of Blood Glucose with Insulin Therapy34. Modern Means of Glycemic Monitoring35. Green Use of Insulin36. Local Issues of Insulin InjectionsSection 9: Psychosocial Aspects of Diabetes37. Breaking the Psychological Resistance to Insulin38. Myths about Insulin TherapySection 10: Public Health and Insulin39. Insulin in the National List of Essential Medicines40. Insulin: The Regulatory and the Public Health Aspects41. Cost Containment and Insulin42. Social Marketing of InsulinSection 11: Challenges in Insulin Treatment in the Young43. Overcoming Challenges of Insulin Therapy in Young44. Creating Support Structure for Children on Insulin Therapy45. Resource Creation for Insulin AvailabilitySection 12: Managing Insulin Therapy in Hospital46. Transitioning Insulin from Intravenous to Subcutaneous47. Managing Patients on Steroids48. Perioperative Management Using Insulin Therapy49. Managing Patients on Enteral and Parenteral Nutrition50. Patients During Labor
